kras mutation and glutathion Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex KRAS G12D: The Next Frontier
KRAS G12D: The Next Frontier in Cancer Therapy MedChemExpress BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site specific metastasis by stimulating glutathione synthesis: Cell Reports Uncovering new therapeutic targets for a common KRAS mutation behind cancer Kras: structure and activation. (A) The Kras gene. Mutations in human Download Scientific Diagram Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell
Pay in 4 interest-free payments of $5.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




